The global surgical site infections market is estimated to create an incremental opportunity of more than US$ 9 Bn by the end of 2032. The sales of surgical site infection prevention products are expected to exceed US$ 5.5 Bn by 2022, projecting growth at a CAGR of nearly 6% to 7% CAGR during the forecast period 2022-2032. Increasing implementation of stringent regulations regarding proper hospital care and sterilization of surgical instruments by regulatory organizations is anticipated to accelerate the demand for surgical site infections prevention solutions in the global market.
| Report Attribute | Details |
| Surgical Site Infections Market Base Year Value (2021) | US$ 5.2 Billion |
| Surgical Site Infections Market Expected Value (2022) | US$ 5.5 Billion |
| Surgical Site Infections Market Anticipated Value (2032) | US$ 9 Billion |
| Surgical Site Infections Market Projected Growth Rate (2022-2032) | 6% to 7% CAGR |
Surgical site infections are infections that occur post-surgery on the operated body part. These infections can result in normal superficial skin infections, but at times they can result in serious infections involving tissues and organs under the skin or implanted material, leading to death if not treated.
These infections commonly occur due to reasons such as use of non-sterilized surgical equipment, contact of the wound with an infected object, and entry of harmful bacteria into the incision or wound, among others.
Surgical site infections remain one of the primary causes of morbidity and mortality, leading to readmission of the patient to the hospital post-surgery. Hence, with increasing awareness regarding the severity of these infections, healthcare organizations are prioritizing surgical site infections prevention before the surgery, during the surgery, and after the surgery. This is estimated to bolster the sales of surgical site infections in the global market.
Rising emphasis on enhancing body and facial aesthetics and increasing customer spending on body implantations have led to a substantial rise in number of surgical procedures across the world, fueling the demand for infection prevention products.
According to a survey by the America Society of Plastic Surgeons, approximately 15.6 million cosmetics surgeries and 6.8 million reconstructive surgical procedures were reported across the U.S. in the year 2020.
Surgical site infection prevention products such as antiseptics & disinfectants, patient-warming products, care supplementary products, surgical staff clothing, and wound care dressing among others are extensively used pre and post surgeries. Thus, increasing number of surgical procedures worldwide is projected to augment the sales of surgical site infections prevention products in the global market.
In addition to this, increasing emphasis on introduction of novel pre and post-surgical care products such as irritation-free wound cleansers, foam dressing, non-adhesive pressure bandages, and others is projected to further favor the growth in the surgical site infections market.
Although there are numerous advantages of surgical site infections control products, high cost of these products and lack of awareness regarding hospital infection prevention and control is hinder the sales on the global market.
In addition to this, low expenditure on preventive care products across certain developing and underdeveloped countries and rising concerns regarding the impact of surgical waste on the environment is posing a challenge to the growth in the surgical site infections market.
Future Market Insights reveals that North America is expected to account for a lion’s share in the global surgical site infections market from 2022 to 2032.
With the increasing number of surgical procedures, a rapid surge in burden of surgical site infections is being witnessed across North America, creating strong demand for hospital infection preventive products.
According to the National Nosocomial Infections Surveillance System, out of 27 million surgical procedures that take place every year in the U.S., nearly 5% or 1.35 million surgeries are reported to be affected by surgical site infections. Hence, governmental and non-governmental organizations are increasingly implementing stringent regulations for hospital care, and post-surgical care to curb the prevalence of surgical site infections. This is estimated to favor the growth in the North America market.
As per FMI, Asia Pacific excluding Japan is anticipated to exhibit growth at a robust CAGR in the global surgical site infections market during the forecast period 2022-2032.
A significant rise in number of births due to cesarean section is being experienced across Asia Pacific, due to increasing complications during labor pain. For instance, according to the Ministry of Health and Family Welfare, more than 14% or 1.9 million births took place through cesarean sections in 2018-2019 across India.
As surgical site infection prevention products are extensively used for proper care of the mother and the baby post-surgery, this rise in maternal mortality rate and longer hospital stays is projected to augment the sales in the Asia Pacific excluding Japan market.
Some of the leading players in the surgical site infections market are Stryker Corporation, Johnson & Johnson, B. Braun Melsungen Ag, Kimberly-Clark Corporation, Belimed AG, BD, Surgical Site Infection Prevention LLC, Medtronic, Steris Corporation, bioMerieux SA, and others.
Attributed to the presence of such high number of participants and increasing advanced surgical care products launches, the market is highly competitive.
| Report Attribute | Details |
| Growth Rate | CAGR of 6% to 7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By Phase:
By Infection Type:
By End User:
By Region:
FMI projects the sales of surgical site infections meter in the market is expected to rise at 6% to 7% value CAGR by 2032
The global surgical site infections market is expected to be dominated by North America over the forecast period 2022-2032.
Stryker Corporation, Johnson & Johnson, B. Braun Melsungen Ag, Kimberly-Clark Corporation, Belimed AG, BD, Surgical Site Infection Prevention LLC, Medtronic, Steris Corporation, bioMerieux SA, and others are some of the leading players in the prominent surgical site infections market.
Explore Similar Insights
Surgical Site Infections Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
